Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 19;30(49):7040-5.
doi: 10.1016/j.vaccine.2012.09.061. Epub 2012 Oct 12.

Establishment of a Shigella sonnei human challenge model in Thailand

Ladaporn Bodhidatta  1 , Punnee Pitisuttithum, Supat Chamnanchanant, Karen T Chang, Dilara Islam, Valai Bussaratid, Malabi M Venkatesan, Thomas L Hale, Carl J Mason
Affiliations

Establishment of a Shigella sonnei human challenge model in Thailand

Ladaporn Bodhidatta et al. Vaccine. .

Abstract

In order to establish a human challenge model of Shigella related disease for vaccine testing, a dose-escalating inpatient trial was performed. Three groups of 12 healthy adult volunteers were orally challenged with 93,440 and 1680 CFU of Shigella sonnei strain 53G. Subjects were admitted to the Vaccine Trial Centre (VTC) at Mahidol University in Bangkok, Thailand. The primary purpose of this study was to identify the dose of S. sonnei 53G required to elicit clinical disease in at least 70% of Thai adult subjects. At the highest dose of 1680 CFU, the attack rate was 75%, while at the two lower doses, the attack rate was approximately 50%. This human challenge model, which is the first of its kind in an endemic region, will provide an opportunity for S. sonnei vaccine evaluation in endemic populations.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None of the authors have potential conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Volunteer screening and enrollment.
Fig. 2
Fig. 2
Serum IgA, IgG, and IgM antibody titers (bars represent geometric mean (middle bar) with 95% confidence intervals) against S. sonnei lipopolysaccharide (LPS) of subjects at baseline (closed round symbol), Day 14 (open square symbols) and Day 28 (star symbols) after challenge with S. sonnei 53G at doses of 93, 440 and 1680 colony forming unit (CFU). No significant dose related linear trends were noted.
Fig. 3
Fig. 3
IgA, IgG and IgM antibody secreting cells (ASC) counts (bars represent geometric mean (middle bar) with 95% confidence intervals) to S. sonnei lipopolysaccharide (LPS) of subjects at baseline (closed round symbol), Day 7 (open square symbols) and Day 9 (star symbols) after challenge with S. sonnei 53G at doses of 93, 440 and 1680 colony forming unit (CFU). ASCs were determined by ELISPOT. Significant dose related linear trends P values (linear by linear association) are shown.
See this image and copyright information in PMC

References

    1. WHO. Diarrhoeal Diseases: Shigellosis. Initiative for Vaccine Research (IVR) 2009 Feb; [cited; Available from: http://www.who.int/vaccineresearch/diseases/diarrhoeal/en/index6.html#di...]
    1. Chompook P, Samosornsuk S, von Seidlein L, Jitsanguansuk S, Sirima N, Sudjai S, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ. 2005 Oct;83(10):739–46. - PMC - PubMed
    1. Isenbarger DW, Hoge CW, Srijan A, Pitarangsi C, Vithayasai N, Bodhidatta L, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996–1999. Emerg Infect Dis. 2002 Feb;8(2):175–80. - PMC - PubMed
    1. Kuo CY, Su LH, Perera J, Carlos C, Tan BH, Kumarasinghe G, et al. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001–2004. J Microbiol Immunol Infect. 2008 Apr;41(2):107–11. - PubMed
    1. Hill Gaston JS, Lillicrap MS. Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol. 2003 Apr;17(2):219–39. - PubMed

Publication types

Substances